MindWalk Holdings (HYFT) Cash from Operations (2023 - 2026)
MindWalk Holdings (HYFT) reported Cash from Operations of 2141533.15 for Q1 2026, down 152.71% year-over-year from 4062821.49 in Q1 2025, and down 3.51% quarter-over-quarter from 2068922.74 in Q4 2025.
MindWalk Holdings (HYFT) Cash from Operations (2023 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 4 years of Cash from Operations data on file, last reported at 2141533.15 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 2141533.15, down 152.71% year-over-year; the trailing twelve-month figure through Jan 2026 was 8077726.19 (down 61.94% YoY), and the FY2025 annual result was 4601657.67, down 95.96% from the prior year.
- Cash from Operations slipped to 2141533.15 in Q1 2026 per HYFT's latest filing, from 2068922.74 in the prior quarter.
- Over five years, Cash from Operations peaked at 13274.89 in Q4 2023 and troughed at 3066159.59 in Q3 2025.
- A 4-year average of 1425849.39 and a median of 1331358.73 in 2024 frame the typical range for Cash from Operations.
- On a YoY basis, Cash from Operations climbed as much as 70.95% in 2024 and fell as far as 12278.68% in 2024.
- A 4-year view of Cash from Operations shows it stood at 13274.89 in 2023, then slumped by 12278.68% to 1643255.85 in 2024, then declined by 25.9% to 2068922.74 in 2025, then decreased by 3.51% to 2141533.15 in 2026.
- Business Quant data shows HYFT's Cash from Operations at 2141533.15 in Q1 2026, 2068922.74 in Q4 2025, and 3066159.59 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | -2.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -2.14 Mn |
| Jan 31, 2026 | -2.14 Mn |
| Oct 31, 2025 | -2.07 Mn |
| Oct 31, 2025 | -2.07 Mn |
| Jul 31, 2025 | -3.07 Mn |
| Jul 31, 2025 | -3.07 Mn |
| Apr 30, 2025 | -801,110.71 |
| Apr 30, 2025 | -801,110.71 |
| Jan 31, 2025 | -847,425.50 |
| Jan 31, 2025 | -847,425.50 |
| Oct 31, 2024 | -1.64 Mn |
| Oct 31, 2024 | -1.64 Mn |
| Jul 31, 2024 | -1.33 Mn |
| Jul 31, 2024 | -1.33 Mn |
| Apr 30, 2024 | -1.17 Mn |
| Apr 30, 2024 | -1.17 Mn |
| Jan 31, 2024 | -763,392.57 |
| Jan 31, 2024 | -763,392.57 |
| Oct 31, 2023 | -13,274.89 |
| Oct 31, 2023 | -13,274.89 |